- Home
- ARAY vs FDMT Comparison
ARAY vs FDMT Comparison
Compare ARAY & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARAY
- FDMT
- Stock Information
- Founded
- ARAY 1990
- FDMT 2013
- Country
- ARAY United States
- FDMT United States
- Employees
- ARAY N/A
- FDMT N/A
- Industry
- ARAY Medical/Dental Instruments
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- ARAY Health Care
- FDMT Health Care
- Exchange
- ARAY Nasdaq
- FDMT Nasdaq
- Market Cap
- ARAY 170.1M
- FDMT 192.2M
- IPO Year
- ARAY 2007
- FDMT 2020
- Fundamental
- Price
- ARAY $1.57
- FDMT $6.81
- Analyst Decision
- ARAY Strong Buy
- FDMT Buy
- Analyst Count
- ARAY 1
- FDMT 9
- Target Price
- ARAY $5.00
- FDMT $30.63
- AVG Volume (30 Days)
- ARAY 742.6K
- FDMT 627.7K
- Earning Date
- ARAY 11-05-2025
- FDMT 11-12-2025
- Dividend Yield
- ARAY N/A
- FDMT N/A
- EPS Growth
- ARAY N/A
- FDMT N/A
- EPS
- ARAY N/A
- FDMT N/A
- Revenue
- ARAY $458,505,000.00
- FDMT $33,000.00
- Revenue This Year
- ARAY $5.84
- FDMT $9,921.62
- Revenue Next Year
- ARAY $3.90
- FDMT N/A
- P/E Ratio
- ARAY N/A
- FDMT N/A
- Revenue Growth
- ARAY 2.68
- FDMT N/A
- 52 Week Low
- ARAY $1.14
- FDMT $2.24
- 52 Week High
- ARAY $2.95
- FDMT $17.41
- Technical
- Relative Strength Index (RSI)
- ARAY 56.74
- FDMT 56.27
- Support Level
- ARAY $1.54
- FDMT $6.09
- Resistance Level
- ARAY $1.64
- FDMT $7.21
- Average True Range (ATR)
- ARAY 0.06
- FDMT 0.44
- MACD
- ARAY -0.00
- FDMT -0.04
- Stochastic Oscillator
- ARAY 57.89
- FDMT 58.74
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.